血小板亲环素D驱动胆固醇结晶栓塞相关急性肾损伤和肾梗死
该研究探讨血小板亲环素D(CypD)在胆固醇结晶栓塞诱导的肾脏血栓炎症和损伤中的作用。利用CypD缺陷小鼠及药理学抑制剂(环孢素A抑制CypD,尼氟酸抑制TMEM16F),发现遗传缺失或药物抑制CypD可保护肾功能、减少梗死面积并减轻肾小管损伤。
要点
- 血小板CypD缺失或药物抑制可减轻胆固醇结晶栓塞诱导的肾脏血栓炎症和急性肾损伤。
- 抑制CypD下游效应分子TMEM16F依赖性磷脂酰丝氨酸暴露同样可限制肾损伤。
- 环孢素A和尼氟酸在动物模型中显示出保护肾功能和减少梗死的潜力。
核心结论
- 血小板CypD及其下游磷脂酰丝氨酸暴露是胆固醇结晶诱导血栓炎症的关键介质。
研究设计与样本
- 研究使用CypD缺陷小鼠和药理学抑制剂(环孢素A抑制CypD,尼氟酸抑制TMEM16F)在胆固醇结晶诱导的肾脏血栓炎症和损伤模型中探究CypD的作用。
主要发现
- 向野生型小鼠肾动脉注射胆固醇结晶导致梗死、血栓炎症和急性肾损伤,而CypD缺陷小鼠受到保护。
- 全局或血小板特异性CypD缺失保留肾小球滤过率(GFR)、减少梗死面积并减轻肾小管损伤。
- 环孢素A药理学抑制CypD产生类似保护作用。
- 尼氟酸抑制TMEM16F依赖性磷脂酰丝氨酸暴露减少CypD介导的促凝血活性并限制肾损伤。
临床怎么用
- 靶向血小板CypD或TMEM16F可能成为胆固醇结晶栓塞相关急性肾损伤和肾梗死的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Cholesterol crystal embolism causes arterial thrombosis, ischemic necrosis, and organ dysfunction. Genetic depletion of cyclophilin D reduced cholesterol crystal embolism-induced thromboinflammation and protected organ function. Pharmacological inhibition of cyclophilin D and transmembrane protein 16F limited cholesterol crystal embolism-induced thrombosis and improved kidney function. BACKGROUND: Cholesterol crystal embolism is a severe consequence of advanced atherosclerosis, where intra-arterial cholesterol crystal can trigger organ injury and failure. Cyclophilin D (CypD), a key regulator of the mitochondrial permeability transition pore, promotes procoagulant platelet formation and necrosis. We hypothesized that CypD-dependent procoagulant platelet formation enhances cholesterol crystal embolism-induced thromboinflammatory responses and kidney injury. METHODS: We used CypD-deficient mice and pharmacologic inhibitors (cyclosporine A to block CypD and niflumic acid to inhibit transmembrane protein 16F as a downstream effector of CypD) to determine the role of CypD during cholesterol crystal-induced kidney thromboinflammation and injury. RESULTS: Cholesterol crystal injection into the renal artery caused infarction, thromboinflammation, and AKI in wild-type mice, whereas CypD-deficient mice were protected. Global or platelet-specific CypD deletion preserved GFR, reduced infarct size, and attenuated tubular damage. Pharmacological inhibition of CypD with cyclosporin A conferred similar protection. Inhibition of transmembrane protein 16F-dependent phosphatidylserine exposure with niflumic acid also reduced CypD-mediated procoagulant activity and limited kidney injury. CONCLUSIONS: Our findings identified platelet CypD and downstream phosphatidylserine exposure as key mediators of cholesterol crystal-induced thromboinflammation.
引用
- Li C, Yang L, Ku J, et al. Platelet Cyclophilin D Drives Cholesterol Crystal Embolism-Related Acute Kidney Injury and Kidney Infarction. J Am Soc Nephrol. 2026. PMID: 41961551. doi:10.1681/ASN.0000001088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。